---
title: The Simultaneous Treatment of PC-3 Cells with the DNA-Demethylating Agent Decitabine
  and S-Adenosylmethionine Leads to Synergistic Anticancer Effects
date: '2025-01-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39766901/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250108170848&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: Epigenetic dysregulation is a common feature of cancer.
  Promoter demethylation of tumor-promoting genes and global DNA hypomethylation may
  trigger tumor progression. Epigenetic changes are unstable; thus, research has focused
  on detecting remedies that target epigenetic regulators. Previous studies have suggested
  that concordantly targeting hypomethylation and hypermethylation is beneficial for
  suppressing both the oncogenic and pro-metastatic functions of cancer cells. Therefore,
  ...'
disable_comments: true
---
Background: Epigenetic dysregulation is a common feature of cancer. Promoter demethylation of tumor-promoting genes and global DNA hypomethylation may trigger tumor progression. Epigenetic changes are unstable; thus, research has focused on detecting remedies that target epigenetic regulators. Previous studies have suggested that concordantly targeting hypomethylation and hypermethylation is beneficial for suppressing both the oncogenic and pro-metastatic functions of cancer cells. Therefore, ...